Pretreatment effect of resveratrol on streptozotocin-induced diabetes in rats

Biological Trace Element Research

Volumn 118, Issue 3, 2007, Pages 244-249

  Aribal Kocatürk, Pelin ^a   Özelçi Kavas, Güzin ^a   İren Büyükkağnici, Demet ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Catalase; Copper; Diabetes; Malondialdehyde; Nitric oxide; Resveratrol; Superoxide dismutase; Zinc

Indexed keywords

CATALASE; COPPER; MALONALDEHYDE; NITRATE; NITRITE; RESVERATROL; STREPTOZOCIN; SUPEROXIDE DISMUTASE; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENZYME ACTIVITY; HEART RATE; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

RATTUS;

EID: 35048825260     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12011-007-0031-y     Document Type: Article

References (27)

1. Prasad K, Mantha SV, Muir AD, Westcott ND (2000) Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism. Mol Cell Biochem 206:141-150
2. Rösen P, Nawroth PP, King G, Möller W, Tritschle H-J, Packer L (2001) The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17:189-212
3. Tsubouchi H, Inoguchi T, Sonta T, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H, Utsumi H, Nawata H (2005) Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement. Free Radic Biol Med 39(4):444-452
4. Limaye PV, Raghuram N, Sivakami S (2003) Oxidative stress and gene expression of antioxidant enzymes in the renal cortex of streptozotocin-induced diabetic rats. Mol Cell Biochem 243:147-152
5. Steven RB, Sutherland DER, Ansite JD, Saxena M, et al (1997) Insulin down-regulates the inducible nitric oxide synthase pathway: nitric oxide as cause and effect of diabetes. J Immunol 159:5329-5335
6. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J (2000) Consequence of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 26:163-176
7. Uriu-Adams JY, Keen CL (2005) Copper, oxidative stress, and human health. Mol Aspects Med 26(4-5):268-298
8. 67 Cu metabolism and oxidant defense in the rat. J Nutr Biochem 16(5):312-320
9. Gonzalez E, Rosello-Catafau J, Jawerbaum A, Sinner D, et al (2000) Pancreatic nitric oxide and oxygen free radicals in the early stages of streptozotocin-induced diabetes mellitus in the rat. Braz J Med Biol Res 33(11):1335-1342
10. Schnedi WJ, Ferber S, Johnson JH, Newgard CB (1994) STZ transport and cytotoxicity. Diabetes 1326-1333
11. Chen H, Carison EC, Pellet L, Moritz JT, Epstein PN (2001) Overexpression of metallothionein in pancreatic β-cells reduces streptozotocin-induced DNA damage and diabetes. Diabetes 50:2040-2046
12. Rodrigo R, Bosco C (2006) Oxidative stress and protective effects of polyphenols: comparative studies in human and rodent kidney, a review. Comp Biochem Physiol C 142:317-327
13. Chander V, Tirkey N, Chopra K (2005) Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism. Toxicology 210:55-64
14. Olas B, Nowak P, Kolodziejczyk J, Ponczek M, Wachowicz B (2006) Protective effects of resveratrol against oxidative/nitrative modifications of plasma proteins and lipids exposed to peroxynitrite. J Nutr Biochem 17:96-102
15. Winterbourn CC, Hawkins RE, Brian M, Carrel RW (1975) Red cell superoxide dismutase activity. J Lab Clin Med 85:337-350
16. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121-126
17. Yoshioka T, Kawada K, Shimada T, Mori M (1979) Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol 135:372-376
18. Miles AM, Wink DA, Cook JC, Grisham MB (1996) Determination of nitric oxide using fluorescence spectroscopy. Methods Enzymol 268:105-120
19. Nims RW, Cook JC, Krishma MC, Christodoulou D, Poore CM, Miles AM, et al (1996) Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol 268:93-105
20. Perkin-Elmer (1973) Analysis of serum determination of copper and zinc (BC-C) in analytical method for atomic absorption spectrophotometry. Perkin-Elmer, Norwalk
21. Rosner F, Gorfien PC (1968) Erythrocyte and plasma zinc and magnesium levels in health and disease. J Lab Clin Med 72:213-219
22. Doganay S, Borazan M, Iraz M, Cigremis Y (2006) The effect of resveratrol in experimental cataract model formed by sodium selenite. Curr Eye Res 31:147-153
23. Quiney C, Dauzonne D, Kern C, Fourneron JD, Izard JC, Mohammad RM, Kolb JP, Billard C (2004) Flavones and polyphenols inhibit the NO pathway during apoptosis of leukemia B-cells. Leuk Res 28:851-861
24. Brandao-Nero J, Siva CAB, Figueiredo NB, Shuhama T, Holanda MBS, Diniz JMM (2000) Zinc kinetics in insulin-dependent diabetes mellitus patients. Biometals 13:141-145
25. Etzel KR, Cousins RJ (1983) Hyperglycemic action of zinc in rats. J Nutr 113:1657-1663
26. Ahmad A, Syed FA, Singh S, Hadi SM (2005) Prooxidant activity of resveratrol in the presence of copper ions: mutagenicity in plasmid DNA. Toxicol Lett 159:1-12
27. Azmi AS, Bhat SH, Hadi SM (2005) Resveratrol-Cu (II) induced DNA breakage in human peripheral lymphocytes: implications for anticancer properties. FEBS Lett 579:3131-3135